Summit Trail Advisors LLC Grows Stake in The Clorox Company (NYSE:CLX)

Summit Trail Advisors LLC boosted its position in The Clorox Company (NYSE:CLX) by 2.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,480 shares of the company’s stock after purchasing an additional 213 shares during the period. Summit Trail Advisors LLC’s holdings in Clorox were worth $1,544,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Prospera Private Wealth LLC purchased a new position in Clorox during the third quarter worth $27,000. Innealta Capital LLC purchased a new position in Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC boosted its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. Quarry LP boosted its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Family Firm Inc. acquired a new stake in shares of Clorox during the second quarter worth $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $169.30 on Monday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The business has a 50 day moving average of $162.78 and a two-hundred day moving average of $148.54. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35. The company has a market cap of $20.96 billion, a P/E ratio of 58.99, a PEG ratio of 3.13 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 earnings per share. As a group, analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.88%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CLX shares. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Citigroup lifted their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. DA Davidson boosted their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $155.00.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.57% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.